Advertisement

Pain pp 1153-1156 | Cite as

Risks and Benefits of Opioid Use in Treatment of Chronic/Cancer Pain in Patients with Substance Use Disorder

  • Randall T. BrownEmail author
Chapter

Abstract

Moderate-to-severe pain normally warranting consideration of opioid analgesics may occur in patients with substance use disorder (SUD) or an SUD history. If opioid analgesics are considered, consideration should also be given to enhanced monitoring practices during the course of pain management. Additionally, care should be coordinated with providers of SUD-related care, such as therapists and other mental health consultants, and prescribers of medication-assisted therapies (e.g. naltrexone, buprenorphine, methadone).

Keywords

Opioid use disorder Addiction 

References

  1. 1.
    Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.CrossRefGoogle Scholar
  2. 2.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub; 2013.CrossRefGoogle Scholar
  3. 3.
    Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–45.CrossRefGoogle Scholar
  4. 4.
    Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic Review: Treatment Agreements and Urine Drug Testing to Reduce Opioid Misuse in Patients with Chronic Pain. Ann Intern Med. 2010;152:712–20.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Family MedicineUniversity of Wisconsin School of Medicine & Public HealthMadisonUSA

Personalised recommendations